The day before Donald Trump left the White House, his administration dealt one final, brutal blow to some of America’s most vulnerable patients.
The Centers for Medicare and Medicaid Services announced a policy that, if implemented, will put numerous lifesaving drugs off-limits to Medicare recipients.
Medicare provides health insurance to 63 million seniors and people with disabilities. Trump’s gut punch affects Part D, the section of Medicare that covers most prescription drugs.
The last-minute policy change would allow the private insurance companies that sponsor Part D plans to stop covering many medications in Part D’s “six protected classes” as early as 2022.